Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters

A recent study suggests Tylenol use by mothers during pregnancy may affect infant reproductive organ development. Researchers observed smaller ovaries and uteruses in three-month-old girls exposed to the drug. This exposure was also linked to fewer ovarian follicles and lower reproductive hormone levels. Long-term follow-up is needed to determine implications for future fertility and menopause timing. Current guidelines still recommend Tylenol as safe for pregnancy pain and fever relief.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RqiEfv6
via IFTTT

Read More

Government panel plans to retain rule allowing doorstep drug delivery

A government sub-committee has decided to uphold the 2020 rule for doorstep delivery of medicines, recognizing its critical importance for elderly patients and those living in remote locations. Despite the chemists' request to revoke the rule due to concerns of misuse by digital platforms, the sub-committee concluded that maintaining this service is essential for vulnerable populations, recommending instead a stricter enforcement of the existing regulations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Jzdx9C8
via IFTTT

Read More

Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bid

Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's proposed acquisition of US-based Organon & Co. The deal is expected to significantly bolster Sun Pharma's business position and revenue base. Organon will contribute substantially to the group's earnings after the acquisition. This strategic move will enhance Sun Pharma's scale and geographic reach.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mpojfhz
via IFTTT

Read More

Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drug

In a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its collaboration with Bahiafarma and Bionovis. This partnership offers exclusive rights to supply the public healthcare sector in Brazil, with plans for phased localization of production. This endeavor aims to improve accessibility to critical cancer therapies while fostering local industry growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/75cGBLe
via IFTTT

Read More

Centre may provide 100% funding support for medical testing equipment, says Piyush Goyal

The government will fully fund the acquisition of advanced medical testing equipment. Domestic firms are encouraged to seek technology partnerships and joint ventures. India aims to become a global hub for medical innovation and device development. Hospitals must offer transparent treatment packages and ethical patient care practices. Enhancing interpreter services will improve foreign patient confidence and communication.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zIGLUJt
via IFTTT

Read More

Novartis India to acquire Pfizer's 'Minipress' trademark for Rs 1,250 crore

Novartis India will acquire the Minipress and Minipres trademarks and related intellectual property from Pfizer for about ₹1,250 crore. Minipress XL, used for hypertension and benign prostatic hyperplasia, generated ₹228.6 crore in revenue as of July 2026, according to IQVIA data.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TNo8DCW
via IFTTT

Read More

'No fake Abhayrab vaccine exported': Indian Immunologicals clarifies after Delhi Police seize counterfeit rabies vaccine batch

Indian Immunologicals confirmed no counterfeit Abhayrab vaccine batch was exported. Four individuals were arrested by Delhi Police after seizing fake vaccine vials. The manufacturer stated all vaccine batches undergo independent testing and government certification. This ensures vaccines reach patients through regulated and authorized supply chains. Previous counterfeit batches had triggered international health authority alerts for travelers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/njKqvM9
via IFTTT

Read More